Table 3.

Univariate analysis of clinicopathological factors for OS and DFS in patients with NSCLC (n = 31)

Variables	OS			DFS
	HR	95%CI	P value	HR	95%CI	P value
Age
≤ 55 vs > 55	0.3624	0.1117–1.175	0.0908	0.3255	0.1182–0.8964	0.0299
Gender
Male vs female	0.7042	0.1642–3.020	0.6368	0.4944	0.1269–1.927	0.3101
Smoking
Non-smoker vs smoker	1.698	0.4399–6.552	0.4423	1.672	0.5113–5.469	0.395
Histology
AD vs non-AD	0.9252	0.2659–3.219	0.9027	0.4909	0.1660–1.452	0.1985
Histologic grading
Poorly Moderate and well	2.005	0.6213–6.473	0.2445	2.079	0.7724–5.595	0.1474
Venous Invasion
Negative vs positive	1.352	0.3956–4.619	0.6306	1.237	0.4191–3.653	0.6999
Pathological stage
I/II vs III	0.3045	0.09458–0.9802	0.0462	0.3044	0.1083–0.8553	0.024
Pre-NAC CMTM1_v17
Low vs high	0.3753	0.09230-1.526	0.1708	1.002	0.3533–2.842	0.9971
Post-NAC CMTM1_v17
High vs low	0.1587	0.04462–0.5647	0.0045	0.3099	0.1149–0.8360	0.0207

P value was calculated using a two-sided log-rank test.

AD adenocarcinoma, NAC neoadjuvant chemotherapy, HR hazard ratio (log-rank), CI confidence interval.

Bold values are significant (p < 0.05)